RAPT Therapeutics Inc
RAPT
Get informed when a big investor buys or sells
+ FollowMarket Cap$959.26M
Close$
$32.43
44.1% downside
Current Fair Value
44.1% downsideOvervalued by 44.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $959.26 Million |
|---|---|
| Enterprise Value | $923.92 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-25.49 |
| Beta | 0.44 |
| Outstanding Shares | 26,963,107 |
Return
| Return on Equity | -69.51% |
|---|---|
| Return on Assets | -63.74% |
| Return on Invested Capital | -72.68% |
Valuation & Multiples
| P/E Ratio | -14.81 |
|---|---|
| PEG | 320.3 |
| Price to Sales | - |
| Price to Book Ratio | 11.6 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -8.34 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 6, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0127▼ 2.06% |
|---|---|
| Total Calls | 646,200▲ 159.39% |
| Total Puts | 8,200▼ 1.20% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 101.44%▲ 50.89% |
|---|---|
| Total Invested | $921.50M▲ 162.28% |
| Investors Holding | 108▲ 42.00% |
ESG Score
No data
About RAPT Therapeutics Inc
CEO: Brian Wong